Specific blood metabolite associations with Gout: a Mendelian randomization study

Area of Science:

• Metabolomics
• Genetic Epidemiology
• Systems Biology

Background:

• Gout is a prevalent metabolic disorder with complex, poorly understood links to blood metabolites.
• Understanding these relationships is crucial for developing effective clinical prevention and treatment strategies.

Purpose of the Study:

• To investigate the causal relationships between blood metabolites and gout using a robust Mendelian randomization approach.
• To identify specific metabolites that influence gout risk and explore their underlying metabolic pathways.

Main Methods:

• Bidirectional two-sample Mendelian randomization (MR) analysis utilizing genome-wide association study (GWAS) data for 486 blood metabolites.
• Gout data sourced from FinnGen R8 (74,61 gout cases, 221,323 controls).
• Inverse variance-weighted (IVW) method, heterogeneity and pleiotropy tests, leave-one-out analysis, reverse MR, and Bonferroni/FDR corrections for robust validation.

Main Results:

• Identified 23 statistically significant blood metabolites causally associated with gout risk.
• Metabolites like X-11529 were associated with increased gout risk (OR=1.225), while piperine and stachydrine showed protective effects.
• Enrichment analysis suggested 1-methylxanthine's involvement in gout via the caffeine metabolism pathway.

Conclusions:

• The identification of causal metabolites provides novel insights into gout's complex mechanisms.
• These findings highlight potential therapeutic targets and pathways for future research in gout management.
• This study advances the understanding of metabolic disorder etiology through genetic association analysis.